VHH antibody, nanobody, production services

VHH antibody, nanobody, production services
Product Description

Cortalix provides flexible VHH nanobody production services tailored to your application and quantity needs. We produce research-grade and preclinical-quality VHHs using optimized microbial expression systems, with optional QC including SEC, endotoxin, and functional binding assays. Available as standalone service or follow-up to our discovery pipeline.

Read more Show less

Cortalix B.V.

  • Country/Region:
    Netherlands
  • On CPHI since:
    2025
  • Employees:
    1 - 24
Company types
Academic/Research
Biopharmaceutical company
Contract Research Organisation (CRO)
Contract Service
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
View company profile
Categories
more categories Show less
Specifications
  • Details
    We offer scalable VHH nanobody production in microbial systems (E. coli, Pichia pastoris), optimized for high yield and purity. Formats include monovalent, bivalent, Fc-fusions, and site-specific conjugates. Applications include therapeutic development, preclinical imaging, CAR-T constructs, and diagnostic assay components.
  • Selling Points
    • Scalable microbial expression in E. coli and Pichia pastoris • Multiple formats: VHH-Fc, bivalent, tagged, or conjugated 
    • Quality control options: purity, activity, endotoxin 
    • Rapid timelines and small-to-medium scale delivery 
    • Available as standalone or integrated with discovery
More specifications Fewer specifications

Cortalix B.V.

  • Country/Region:
    Netherlands
  • On CPHI since:
    2025
  • Employees:
    1 - 24
Company types
Academic/Research
Biopharmaceutical company
Contract Research Organisation (CRO)
Contract Service
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
View company profile

More Products from Cortalix B.V. (2)

  • VHH antibody, nanobody, discovery services

    Product VHH antibody, nanobody, discovery services

    Cortalix provides end-to-end nanobody discovery services based on proprietary synthetic and immune VHH libraries. We guide clients from target definition to high-affinity lead candidates, including binder selection, affinity maturation, and engineering into multivalent or functional formats. Our platform s...
  • VHH antibody, nanobody, functionalization services

    Product VHH antibody, nanobody, functionalization services

    Cortalix offers tailored nanobody functionalization services to support downstream applications in imaging, therapy, and analytics. We conjugate VHHs to chelators (DOTA, NOTA), fluorophores, enzymes, or beads using optimized chemistries that preserve binding activity. All modifications are QC-tested for in...